N'N-bis(dichloroacetyl)-1,8-octamethylenediamine (WIN 18446), the most potent of the diamines and one of the least amoebicidal agents, was shown to exert a speci c effect on the testes of CBA mice, while the Leydig cells were unaffected. Spermatogenesis was severely affected after a 42-day treatment period with 125 mg WIN 18446=kg body weight. Large multinucleated cells, vacuolization and the absence of sperm within the testes were evident in most seminiferous tubules. After 15 days of withdrawal of WIN 18446, there was a slight recovery of spermatogenesis and after withdrawal of 42 days a marked recovery of spermatogenesis. The normality or abnormality of this spermatogenic cycle could be evaluated using the semi-quantitative Stages program. There was a signi cant decrease in the diameters of seminiferous tubules of WIN 18446 treated mice, however an almost complete recovery was evident after 42 days of withdrawal of WIN 18446. A signi cant decrease in sperm concentration and sperm morphology was observed for the WIN 18446 treated mice. Various sperm motion parameters were assessed for the different treatment groups and compared to the control group. The female and male fertility indices were assessed and compared for the different treatment groups. Complete recovery of the above-mentioned parameters was evident after 42 days of withdrawal from WIN 18446, and this con rms its potential as a possible contraceptive for animal populations.
In the search for a male contraceptive, numerous compounds have been evaluated which interfere with spermatogenesis, sperm maturation or sperm transport. WIN 18446 (hereafter referred to as WIN) was used as an amoebicide in the clinical treatment of amoebiasis, but displayed anti-spermatogenic activity (Surrey & Mayer 1961) . This relatively non-toxic substance exerted an effect on the seminiferous epithelium, which was completely reversible within a few weeks of withdrawal, while the Leydig cells were unaffected. Studies of the rat model have indicated that spermatogenic arrest is evident (Coulston et al. 1960 , Drobeck & Coulston 1962 , Kar et al. 1966 , Reddy & Svoboda 1967 . WIN administered to humans produces an effective reduction in the numbers of ejaculated sperm and an alteration in their morphology (Heller et al. 1961 (Heller et al. , 1963 . In mice, WIN affects rst the spermatids then the spermatocytes, with severe atrophic changes in the seminiferous tubules (Singh & Dominic 1995) . The optimum dosage of WIN required to produce these anti-spermatogenic effects and the withdrawal periods vary according to the species studied. One drawback associated with this compound in humans is that the consumption of alcohol, concomitant with WIN, inhibits alcohol dehydrogenase activity and induces severe vomiting (the antabuse effect), and research was largely abolished using WIN (Zaneveld & Waller 1989) . This side effect made WIN undesirable for general clinical application to humans. However, there is an increasing need for the development of cost-effective contraceptives for domestic and certain wildlife species, whereby sterility is attained over the shortest possible time. The mouse model was used in this study to test possible differential short-term effects of WIN, which allows extrapolation in terms of its potential use as a male contraceptive in the animal population. In this investigation, in contrast to previous work, the effects of WIN on spermatogenesis were quanti ed using the Stages program, which identi es the spermatogenic stages as outlined by Hess (1990) . The effect of WIN on quantitative sperm motility, sperm concentration, sperm morphology and fertility indices undoubtedly provides crucial information on the shortterm effects of WIN. Quanti cation of sperm motion parameter changes by WIN was evaluated to assess this aspect of sperm functionality. These approaches and techniques can inevitably be applied to other toxicological studies where the contraceptive action and reversibility of compounds are being evaluated.
Materials and methods
The activity of WIN on male reproductive function was examined following oral administration to male CBA mice obtained from the Animal Research Unit of the Medical Research Council (Tygerberg, South Africa). The 8-week-old animals were acclimatized to laboratory conditions for one week prior to experimentation in a housing facility at the University of the Western Cape. Ethical clearance for the care and use of these experimental animals was obtained from the ethical committee of the University of the Western Cape, which is in accordance with the legal requirements of the United Kingdom. These animals were housed ve per cage and were maintained on a diet of commercial mouse feed (Specialist Animal Feeds, Tygerberg and South Africa) and water was available ad libitum. The temperature of the housing facility was 22 to 26¯C and the light settings were 12 h light and 12 h dark.
A dosage of 125 mg=kg body weight was selected as the effective dosage of WIN, and intragastric administration was delivered for a period of 42 days. Forty randomly selected male CBA mice were used for the determination of the contraceptive effect and reversibility of WIN. Ten mice served as controls and received 1% gum tragacanth only. Thirty mice served as the experimental group, of which 10 received 125 mg WIN for 42 days only, another 10 received 125 mg WIN for 42 days followed by 15 days of withdrawal, and the remaining 10 received WIN for 42 days followed by 42 days of withdrawal. These animals were humanely killed by chloroform anaesthesia 24 h after the last administration of WIN and an incision was made through the scrotal skin to expose the reproductive organs. The testes were excised, all adipose tissue and blood vessels were removed.
Testicular histology
One testis per animal was rinsed in Hams-F10 at 32¯C and pH 7.4 and xed in Bouins xative for the histological assessment of the structure of the testes. Testicular tissue was processed in a Histokinette, embedded in wax blocks, sectioned at 5 mm and stained with haematoxylin and eosin using routine procedures. The testicular sections were visually analysed with a Universal-light research microscope (Zeiss D-7082, Germany). The Stages program was used to identify the spermatogenic stages in the mouse as outlined by Hess (1990) . For each of the ve animals, two dimensions were measured for the six randomly selected seminiferous tubule diameters per testis section. A calibrated eyepiece micrometer was utilized for measurements of testicular diameters.
The epididymis was excised, all excess adipose tissue and blood vessels were removed. The cauda region of the epididymis was located, an incision was made through the coiled duct, light pressure was applied to this region, and sperm was extruded.
Sperm concentration
The cauda epididymidis from each of the control and experimental mice was evaluated for the sperm concentration. To a 2.5% Sorensons phosphate buffered gluteraldehyde solution, 10 ml of sperm was added and agitated well. A Neubauer haematocytometer was used for determination of the sperm concentration (610 6 ) for each mouse, and counts were determined under a light microscope (Olympus CH, Japan).
Scanning electron microscopy
For each experimental animal, 20 ml of extruded sperm were xed in 1 ml of 2.5% Sorensons phosphate buffered gluteraldehyde for at least 24 h. The protocol for the processing of tissues for scanning electron microscopy was followed according to the methods employed by van der Horst et al. (1989) . A Hitachi X-650 Scanning Electron Microanalyser was used to view the specimens and to determine the percentages of normal sperm. The accelerating voltage used 
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was 25 kV and images were digitally captured on Imageslave for Windows (Version 2.11).
Sperm motility
Cauda epididymal sperm was aspirated into Hams-F10 and allowed to swim out before the motility patterns were recorded. Approximately 5 ml of sperm suspension was pipetted into a motility chamber with 1 ml Hams-F10 medium on a preheated stage. Sperm motility was recorded using a 106objective lens with a videocamera (JVC Avicol, Model VF-1900E), which was connected to a videocassette recording system (JVC Model CR-6060ET) attached to an inverted microscope. To ensure that a representative sample of sperm was obtained, 10 microscopic elds were recorded, for at least 15 s each, to incorporate at least 50 motile sperm per animal. The sperm motility was recorded onto VHS cassettes analysed at 50 Hz and the motility parameters were assessed. The sperm motility quanti er (SMQ) system is a computer aided sperm analysis (CASA) system that has been validated. The kinematic parameters measured with this system are explained in Table 1 .
Mating experiments
Twenty randomly selected CBA mice were used for the assessment of the WIN-treated male mice to impregnate virgin female mice. Each of the four treatment groups consisted of ve mice and received WIN for the stipulated periods. After treatment, male fertility was assessed by placing each control and treated male with virgin two 8-week-old CBA female mice and allowed to mate for at least two oestrous cycles. A male was considered fertile if he impregnated any of the females with which he was housed. The female mice were monitored to establish whether the males impregnated them and this continued until the pups were born. Birth of pups in the various groups was recorded. Male and female fertility indices were determined according to a formula in Table 2 .
Statistics
All data were statistically analysed with a computer software package, Medcalc (Version 3.0, Belgium). ANOVAs were performed in conjunction with the Student-Newman-Keuls test for all pairwise comparisons where P < 0.05 was considered signi cant.
Results
The spermatogenic cycle in the mouse seminiferous epithelium consists of 12 stages, of which many were identi able in the control group. The stage depicted in Fig 1 is stage VI of spermatogenesis. The treatment Fig 3. Severely depleted seminiferous tubules were still present, but considerably fewer of these tubules were observed. The seminiferous tubules displayed a combination of stages, which made it dif cult to discern the exact stage in the cycle of the seminiferous epithelium. However, stage X could be clearly identi ed in the seminiferous tubules of a number of these mice. Mice treated with WIN for 42 days followed by 42 days of withdrawal exhibited a marked recovery of spermatogenesis, as illustrated in Fig 4. Generally, the morphology of the germinal epithelium was normal in most of the tubules when judged by the Stages program (version 2.2). Table 3 represents the seminiferous tubule diameters for the various treatment groups. Treatment of mice for 42 days with WIN produced a signi cant decline (P < 0.05) in seminiferous tubule diameters of control animals from 228.0 mm to 190.9 mm. After 15 days of WIN withdrawal, the seminiferous tubule diameters increased to 203.6 mm, which was signi cantly different (P < 0.05) from the other three groups. The diameters of the seminiferous tubules increased to 217.0 mm after 42 days withdrawal of WIN, which was not signi cantly different (P > 0.05) from the control group. Figure 5 depicts the sperm concentration (610 6 sperm=ml) expressed as means § SEM of the cauda epididymidis for the control and treatment groups. The examination of cauda epididymal sperm concentrations showed a signi cant (P < 0.05) decrease in the mice which received WIN for 42 days, as compared to the control group which received gum tragacanth only. After 42 days of WIN treatment there was a signi cant drop in sperm concentration from 60.57610 6 sperm=ml to 13.36610 6 sperm=ml. A withdrawal period of 15 days after WIN treatment yielded a slight recovery in sperm concentration which was still signi cantly lower than the control group. The sperm concentration of the 42 days of withdrawal group approached the normal concentration, but differed signi cantly from the other treatment groups.
Sperm concentration

Sperm morphology
The percentage of morphologically normal cauda epididymal sperm was calculated after scoring 100 sperms per animal using the scanning electron microscope. The results are illustrated in Table 4 . The mice, which received WIN only and WIN for 42 days followed by 15 days of withdrawal showed a statistically signi cant difference (P < 0.05) in the percentage of normal sperm morphology as compared to the control group. Mice, which received WIN for 42 days followed by 42 days of withdrawal did not show any signi cant difference (P > 0.05) in sperm morphology from the control group. The highest percentage of abnormal forms occurred in the 42 day WIN treatment group (50.6%) followed by the 15 days of WIN withdrawal group (41.0%). The most common abnormalities of sperm observed were deformed heads, loose heads, kinks in the midpiece, and retention of cytoplasmic droplets. Figure 6 is an electron micrograph, which depicts a morphologically abnormal sperm and a normal sperm, and is a representative illustration of the WIN treatment group. The average pore size of the polycarbonate lters is 3.0 mm in diameter and serves as a scale in the scanning electron micrographs.
Sperm motility
Cauda epididymal sperm motion parameters of the three treatment groups were compared to the control group and statistically evaluated (Table 5) . No signi cant differences were observed between groups for the following parameters: VCL, MAD and CURV. Comparison of the treatment groups to the control group showed statistically signi cant differences (P < 0.05) for kinematic parameters: VSL, LIN, mnALH, BCF, VAP, WOB and STR. DNC and mxALH were signi cantly different (P < 0.05) when the WIN-treated group was compared to the control group.
Effect on males to impregnate females
The female and male fertility indices are shown in Table 2 . Males from the WINtreated group paired with females resulted in 20% of the females giving birth. When males from the 15 days of WIN withdrawal group were paired with females, 42.86% gave birth. Seventy per cent of the females paired with males from the 42 days of WIN withdrawal group gave birth. The male fertility index was higher than the female fertility index (females which gave birth to pups) for all the treatment groups. The percentages of fertile males and of females which gave birth to pups were signi cantly less (P < 0.05) for the WIN and the 15 days of WIN withdrawal groups than for the control and 42 days of WIN withdrawal groups.
Discussion
This investigation revealed that WIN has a profound impact on the spermatogenic cells, leaving the Leydig cells intact (Beyler et al. 1961 , MacLeod 1961 , Zaneveld & Waller 1989 . The seminiferous tubules produce sperm in different, successive waves, as seen in the histological sections; however, some tubules were unaffected by WIN. The majority of tubules showed signs of severe degenerative changes, and this could be attributed to the fact that a higher dosage of WIN or longer duration of treatment is required to produce damage in all the seminiferous tubules. The occurrence of multinucleated cells within the seminiferous tubules, established in this investigation, is consistent with the ndings in the rat (Beyler et al. 1961 , Drobeck & Coulston 1962 , Reddy & Svoboda 1967 and in the mouse (Singh & Dominic 1995) . It has been postulated that these multinucleated cells arise by possible fusion of damaged spermatids or nuclear division without cytoplasmic separation (Singh & Dominic 1995) . Another prominent feature observed in most of the seminiferous tubules of the WINtreated mice was the appearance of vacuoles also found by other investigators (Drobeck & Coulston 1962 , Flores & Fawcett 1972 , Singh & Dominic 1995 . Withdrawal of WIN for up to 42 days produced a marked recovery of spermatogenesis. However, there were a few partially depleted seminiferous tubules, and diminished vacuolization, and a few multinucleated cells were observed. Thus, almost complete recovery of spermatogenesis occurred within the seminiferous tubules. This study, in contrast to previous investigations, clearly indicates recovery of the spermatogenic wave after treatment and withdrawal of WIN; as evaluated semi-quantitatively by means of the Stages program. Even though this anti-spermatogenic action of WIN is convincingly demonstrated, the exact mechanism by which WIN induces such effects is not clearly elucidated.
A decrease in seminiferous tubule diameters was found in the WIN-treated mice. However, after 15 days of withdrawal of WIN, a slight increase in seminiferous tubule diameters was evident. Full recovery to normal seminiferous tubule diameters was attained after 42 days of WIN treatment followed by 42 days of withdrawal. These ndings conform to the seminiferous tubule diameter reductions in the rat (Beyler et al. 1961 , Heller et al. 1961 , Drobeck & Coulston 1962 , Kar et al. 1966 ) and in the mouse (Singh & Dominic 1995) .
In this study, the interstitial (Leydig) cells were apparently unaffected by WIN, and retained their normal morphology. These ndings are in agreement with the reported ndings in the rat (Coulston et al. 1960 , Beyler et al. 1961 , Kar et al. 1966 ) and the musk shrew (Singh & Dominic 1980) . Quantitative evaluation of the micrographs of control versus experimental animals seems to indicate that Leydig cell numbers remain fairly constant in groups of three to ve cells among two to three seminiferous tubule cross sections.
Sperm concentration
The spermatogenic cycle in the mouse is approximately 34.5 days, and after 42 days of WIN treatment, the entire spermatogenic cycle is targeted, as is sperm undergoing epididymal maturation. After 42 days of WIN treatment, a 47.2% decline in the sperm concentration was observed. Most seminiferous tubules were affected and some sperm eventually reached the epididymis. A study conducted in inmates showed that sperm counts dropped from an average of 113 million=cc to 4 million=cc within weeks of treatment with WIN (Heller et al. 1961) . Heller et al. (1963) showed that WIN administered to humans produced an effective reduction in the numbers of ejaculated spermatozoa, an alteration in their morphology, or a reduction in sperm motility. Therefore, sperm concentration after 15 days of withdrawal of WIN could possibly have been sperm from unaffected seminiferous tubules, which had reached the epididymidis. Recovery of spermatogenesis after cessation of dosing with WIN is almost immediate, and this suggests that WIN acts at the level of the testes by inhibiting spermatogenesis.
Sperm morphology
A profound increase in aberrations in sperm morphology coincided with the decline in sperm concentration. The high percentage of morphologically abnormal epididymal sperm indicates that WIN affects sperm development. Investigations by Heller et al. (1961) showed that abnormal sperm forms were exceptionally high once the low counts had been attained. Scanning electron micrographs revealed damage to sperm with an abundance of retained cytoplasmic droplets. Since a high percentage of morphologically abnormal epididymal sperm was noted in the WIN-treated group, it can be deduced that the differential development of sperm in the testes is affected. The decrease in morphological abnormal forms after withdrawal of WIN can be attributed to a slow recovery of spermatogenesis. It is evident that spermatogenesis has returned to normal, and therefore more morphologically normal sperm was present in the epididymis. The trend in sperm morphology follows a similar pattern to that of the sperm concentration, which suggests that a decreased sperm count and sperm abnormality may be associated. Thus, after 42 days of withdrawal of WIN, virtually complete recovery was attained and the percentage of morphologically normal sperm returned to normal.
Sperm motility
Sperm motility is attained as sperm migrate through the epididymis, and therefore motility is chie y a parameter of posttesticular function (Consentino & Cockett 1986) . Kinematic parameters were evaluated for cauda epididymal sperm of the mouse for the control and treatment groups. The decreased VSL and LIN of the sperm from the control group clearly indicate that they possess less linear trajectories. Sperm from the WIN treatment group exhibited the largest variation in kinematic parameters. The pronounced changes in motion parameters were an increase in VSL, VAP, LIN, ALH, BCF and DNC, while STR declined. An increase in sperm vigour (VSL, VAP and VCL) indicates that sperm tend to swim more rapidly with greater linearity (increased LIN). There was a signi cant increase in WOB, which indicates little deviation of sperm head from the path of progression. It is evident that sperm from the WIN treatment group exhibited the largest variations in sperm kinematics; as the development of sperm in the testes had been affected. The increase in LIN clearly indicates that sperm followed a more linear motion pattern. The decrease in sperm vigour (VCL, VSL and VAP) for the WIN and 15 days of withdrawal groups indicate that the sperm tended to swim less rapidly, but with greater linearity (increased LIN). After 42 days of withdrawal of WIN, sperm vigour returned to normal. LIN, ALH, DNC, WOB and STR virtually returned to control values. There was a noticeable improvement in most of the kinematic parameters after 42 days of withdrawal. These parameters clearly resemble closeness to the control values; except for BCF, which remained considerably higher. Furthermore, this study indicates that quantitative sperm motility is a useful technique for monitoring subtle changes in sperm motility after treatment with pharmaceutical agents and toxic substances.
Effect on males to impregnate females
In the present study, the male fertility index for the controls indicates that all these males had impregnated the females with whom they were paired. Following 15 and 42 days of withdrawal of WIN, the male fertility index rose, which meant that more males were able to impregnate the females. A withdrawal of WIN for 42 days resulted in most of the males becoming fathers. The females who paired with the males of the control group did not all give birth to pups. The female fertility index was signi cantly reduced, which could mean that WIN impairs the formation and quality of sperm that reaches the female. The female fertility index of the 15 and 42 days of withdrawal of WIN groups increased, thus indicating that fertility had improved in those males. This signi es that 42 days is suf cient to yield an almost complete recovery of the normal fertility index. By extending the withdrawal period, the male and female fertility indices are most likely to rise and attain normal values.
Conclusion
The results of this investigation indicate that WIN induces marked anti-spermatogenic effects of the testis, which is completely reversible upon cessation of treatment. This study, in contrast to previous investigations, shows that the full spermatogenic wave recovers after withdrawal of WIN, as quanti ed by the Stages program. The failure of WIN to induce regressive changes in the Leydig cells suggests that WIN does not affect the endocrine function of the testis. Many of our ndings of the contraceptive effect of WIN are in agreement with the literature, but it has not previously been shown that the spermatogenic cycle returns to normal, as evaluated by the Stages program. Our results support the ndings that the antifertility effects of WIN, produce an effective reduction in sperm count and sperm morphology. This study has elucidated the changes in sperm motion parameters following treatment and withdrawal of WIN to male mice. Also, the female and male fertility indices have been shown in this study. These ndings provide important information of the effects of the short-term treatment of WIN. The rapid contraceptive effect of WIN as well as the rapid, complete reversibility after withdrawal to restoration of fertility indicates that it has a high potential use as a male contraceptive in animals. Further experimentation is required, because of species differences, and this work cannot be applied to any species until further testing is completed.
